My thoughts are simplistic: conjecture until Top Line report is written is worthless banter and has no real value. Depending on the TLR Mr Ehrlich will determine and define INNOVATIONS PHARMACEUTICALS direction. This of course is just my opinion. No offense is intended. Guess I’m a bit edgy waiting. But something big is about to happen that’s for sure. RP